Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chieh-Hsin Lin

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Neuropsychiatric Disease and Treatment|November 2, 2017
Bupropion interferes with the image diagnosis of Parkinson's diseaseChieh-Hsin Lin, Hsien-Yuan Lane
Antioxidants (Basel, Switzerland)|November 27, 2021
Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective StudyChieh-Hsin Lin, Hsien-Yuan Lane
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 23, 2021
In Reply: Trough Melatonin Levels Have No Physiological or Clinical RelevanceChieh-Hsin Lin, Hsien-Yuan Lane
Schizophrenia Research|May 25, 2023
Sodium benzoate: A novel multi-target pharmaceutical approach to rescue clozapine-resistant schizophreniaChieh-Hsin Lin, Hsien-Yuan Lane
The International Journal of Neuropsychopharmacology|August 20, 2022
Diagnosing Alzheimer's Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood BiomarkersHsien-Yuan Lane, Chieh-Hsin Lin
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 16, 2025
Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trialChieh-Hsin Lin, Hsien-Yuan Lane
European Archives of Psychiatry and Clinical Neuroscience|June 14, 2026
Superoxide dismutase and glutathione interact to determine cognitive outcome among people with subjective cognitive decline (SCD): a prospective studyChieh-Hsin Lin, Hsien-Yuan Lane
The International Journal of Neuropsychopharmacology|April 17, 2022
Blood D-Amino Acid Oxidase Levels Increased With Cognitive Decline Among People With Mild Cognitive Impairment: A Two-Year Prospective StudyChieh-Hsin Lin, Hsien-Yuan Lane
Translational Psychiatry|August 5, 2025
Sodium benzoate treatment decreased amyloid beta peptides and improved cognitive function among patients with Alzheimer's disease: secondary analysis of a randomized clinical trialChieh-Hsin Lin, Hsien-Yuan Lane
Frontiers in Psychiatry|March 16, 2019
Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative StressChieh-Hsin Lin, Hsien-Yuan Lane
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Neuropsychiatric Disease and Treatment|November 2, 2017
Bupropion interferes with the image diagnosis of Parkinson's diseaseChieh-Hsin Lin, Hsien-Yuan Lane
Antioxidants (Basel, Switzerland)|November 27, 2021
Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective StudyChieh-Hsin Lin, Hsien-Yuan Lane
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 23, 2021
In Reply: Trough Melatonin Levels Have No Physiological or Clinical RelevanceChieh-Hsin Lin, Hsien-Yuan Lane
Schizophrenia Research|May 25, 2023
Sodium benzoate: A novel multi-target pharmaceutical approach to rescue clozapine-resistant schizophreniaChieh-Hsin Lin, Hsien-Yuan Lane
The International Journal of Neuropsychopharmacology|August 20, 2022
Diagnosing Alzheimer's Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood BiomarkersHsien-Yuan Lane, Chieh-Hsin Lin
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 16, 2025
Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trialChieh-Hsin Lin, Hsien-Yuan Lane
European Archives of Psychiatry and Clinical Neuroscience|June 14, 2026
Superoxide dismutase and glutathione interact to determine cognitive outcome among people with subjective cognitive decline (SCD): a prospective studyChieh-Hsin Lin, Hsien-Yuan Lane
The International Journal of Neuropsychopharmacology|April 17, 2022
Blood D-Amino Acid Oxidase Levels Increased With Cognitive Decline Among People With Mild Cognitive Impairment: A Two-Year Prospective StudyChieh-Hsin Lin, Hsien-Yuan Lane
Translational Psychiatry|August 5, 2025
Sodium benzoate treatment decreased amyloid beta peptides and improved cognitive function among patients with Alzheimer's disease: secondary analysis of a randomized clinical trialChieh-Hsin Lin, Hsien-Yuan Lane
Frontiers in Psychiatry|March 16, 2019
Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative StressChieh-Hsin Lin, Hsien-Yuan Lane
Pageof 12